PortViewPortView
Alps logo

Alps (ALPS) Stock Analysis

NASDAQHealthcareBiotechnology

$0.37-3.77%
1-year price historyRange $0.27 – $12.01
52-week range$0.37
$0.23$2.90

What Alps does

Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.

Key metrics

Market cap
$62.37M
P/E (TTM)
-0.03
EPS (TTM)
$-14.29
Beta
-0.06
Dividend yield
0.00%
Revenue / share
$0.96
50-day avg
$0.45
200-day avg
$0.82
52-week high
$2.90
52-week low
$0.23
CEO
Seng Kong Tham

ETFs linked to ALPS

Broad-market and Healthcare sector ETFs an investor holding Alps is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ALPS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ALPS in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Alps?
Alps trades under the ticker ALPS on NASDAQ.
Which exchange is ALPS listed on?
ALPS is listed on NASDAQ.
What sector does Alps operate in?
Alps is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ALPS in a portfolio?
PortView shows ALPS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.